-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gvr3E8T/qtDw0TSfj77p+m/O1mPytfGj5mMbbElIDQIw0Fje9cwEBK1PvHxwhIQg Rto8DFuRvZZv/2QZ5Q1bJw== 0000950123-10-071520.txt : 20100803 0000950123-10-071520.hdr.sgml : 20100803 20100803083738 ACCESSION NUMBER: 0000950123-10-071520 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100803 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20100803 DATE AS OF CHANGE: 20100803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 10985839 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 8-K 1 b81968e8vk.htm HAEMONETICS CORPORATION e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 3, 2010
HAEMONETICS CORPORATION
(Exact name of registrant as specified in its charter)
         
Massachusetts   1-14041   04-2882273
(State or other jurisdiction
of incorporation) 		  (Commission
File Number) 		  (I.R.S. Employer
Identification No.)
     
400 Wood Road   02184
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code 781-848-7100
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders
Haemonetics Corporation’s Annual Meeting of Stockholders was held on July 29, 2010. At the meeting:
1) Susan Barlett Foote, Pedro P. Grandaillo, and Mark W. Kroll, Ph.D. were elected to serve as directors of Haemonetics; and
2) The selection of Ernst & Young LLP to serve as the independent registered public accounting firm of Haemonetics Corporation for fiscal year 2011 was ratified.
Below are the number of votes cast for or against, the number of abstentions and the number of broker non-votes:
Election of Directors:
                         
Director   Votes For   Withheld   Broker Non-Votes
Susan Barlett Foote
     22,338,135       306,597       819,435  
Pedro P. Granadillo
     22,339,228       305,504       819,435  
Mark W. Kroll Ph.D.
     22,349,243       295,489       819,435  
Ratification of Auditors:
             
Votes For   Votes Against   Abstain   Broker Non-Votes
22,616,505
  844,005   3,657   —

2

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
 

HAEMONETICS CORPORATION
(Registrant)
 		  
Date: August 3, 2010  /s/ Christopher Lindop    
  Christopher Lindop, Chief Financial Officer   
  and VP Business Development   
 

3

-----END PRIVACY-ENHANCED MESSAGE-----